1. Home
  2. KITT vs PULM Comparison

KITT vs PULM Comparison

Compare KITT & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nauticus Robotics Inc.

KITT

Nauticus Robotics Inc.

HOLD

Current Price

$0.76

Market Cap

8.1M

Sector

Industrials

ML Signal

HOLD

Logo Pulmatrix Inc.

PULM

Pulmatrix Inc.

HOLD

Current Price

$2.42

Market Cap

9.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KITT
PULM
Founded
2014
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1M
9.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KITT
PULM
Price
$0.76
$2.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.2M
9.3K
Earning Date
11-14-2025
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,688,840.00
$3,000.00
Revenue This Year
$2,936.06
N/A
Revenue Next Year
N/A
$134.88
P/E Ratio
N/A
N/A
Revenue Growth
95.38
N/A
52 Week Low
$0.69
$2.15
52 Week High
$15.21
$10.40

Technical Indicators

Market Signals
Indicator
KITT
PULM
Relative Strength Index (RSI) 39.22 40.77
Support Level $0.82 $2.38
Resistance Level $1.06 $2.53
Average True Range (ATR) 0.12 0.11
MACD -0.03 0.02
Stochastic Oscillator 2.22 21.53

Price Performance

Historical Comparison
KITT
PULM

About KITT Nauticus Robotics Inc.

Nauticus Robotics Inc develops fully electric autonomous robotic solutions for subsea applications. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing related software to both the commercial and defense business sectors. The company's addressable markets include upstream, midstream, and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research, and subsea mining.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Share on Social Networks: